ArticleCancer imaging : the official publication of the International Cancer Imaging Society2026
Risk stratification of advanced extranodal extension in retropharyngeal lymph nodes for nasopharyngeal carcinoma: a multi-center study.
Article in Cancer imaging : the official publication of the International Cancer Imaging Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
backgroundThis study aimed to refine risk stratification of advanced extranodal extension (ENE) in retropharyngeal lymph nodes (RLNs) and evaluate its prognostic significance.
methodsA total of 1,373 non-metastatic NPC patients at three centers between 2011 and 2021 were retrospectively enrolled. For advanced RLN ENE, we documented all involved structures, maximum axial diameter (MAD), presence of lymph node necrosis (LNN), and bilaterality. High-risk structures were identified using adjusted hazard ratios and LASSO-Cox models. Multivariable Cox models and Kaplan-Meier analyses were used to evaluate associations with survival outcomes.
resultsOf the 1,373 patients, 1061 had RLN metastasis, including 168 with advanced RLN ENE. Involvement of interval structures, the lower cranial nerves region, internal jugular vein, and longus capitis muscle was classified as high-risk, whereas isolated internal carotid artery involvement was low-risk. Advanced RLN ENE with high-risk structure involvement or LNN was defined as high-risk RLN ENE. High-risk RLN ENE was an independent adverse prognostic factor for NPC. N1/N2 patients with high-risk RLN ENE showed survival comparable to N3 disease.
conclusionsHigh-risk RLN ENE is an independent adverse prognostic factor in NPC. N1/N2 patients with high-risk RLN ENE exhibit N3-like survival, supporting its potential incorporation into future refinements of N staging.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.